BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 16110833)

  • 1. Correction to Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein.
    J Cell Mol Med; 2024 Apr; 28(7):e18117. PubMed ID: 38494846
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutrophil infiltration of the colon is independent of the FPR1 yet FPR1 deficient mice show differential susceptibilities to acute versus chronic induced colitis.
    Farooq SM; Stadnyk AW
    Dig Dis Sci; 2012 Jul; 57(7):1802-12. PubMed ID: 22383080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The main functions and structural modifications of tripeptide N-formyl-methionyl-leucyl-phenylalanine (fMLP) as a chemotactic factor.
    Yang KH; Fang H; Ye JS; Gong JZ; Wang JT; Xu WF
    Pharmazie; 2008 Nov; 63(11):779-83. PubMed ID: 19069235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic peptides. Mechanisms, functions, and possible role in inflammatory bowel disease.
    Nast CC; LeDuc LE
    Dig Dis Sci; 1988 Mar; 33(3 Suppl):50S-57S. PubMed ID: 3278869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bacterial chemotactic peptides on intestinal inflammation in animal models of acute and chronic "relapsed" colitis.
    Hernández GA; Valentín MR; Appleyard CB
    Dig Dis Sci; 2005 Aug; 50(8):1444-53. PubMed ID: 16110833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial peptides enhance inflammatory activity in a rat model of colitis.
    García-Lafuente A; Antolín M; Guarner F; Vilaseca J; Malagelada JR
    Digestion; 1996; 57(5):368-73. PubMed ID: 8886582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between bacterial peptides, neutrophils and goblet cells: a possible mechanism for neutrophil recruitment and goblet cell depletion in colitis.
    Leiper K; Campbell BJ; Jenkinson MD; Milton J; Yu LG; Democratis J; Rhodes JM
    Clin Sci (Lond); 2001 Oct; 101(4):395-402. PubMed ID: 11566077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic peptide-induced acute colitis in rabbits.
    LeDuc LE; Nast CC
    Gastroenterology; 1990 Apr; 98(4):929-35. PubMed ID: 2155846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of inflammatory mediators secretion by chemotactic peptides in rat colitis model.
    Ledesma de Paolo MI; Celener Gravelle P; De Paula JA; Panzita MT; Bandi JC; Bustos Fernandez L
    Acta Gastroenterol Latinoam; 1996; 26(1):23-30. PubMed ID: 9137653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute colitis produced by chemotactic peptides in rats and mice.
    Chester JF; Ross JS; Malt RA; Weitzman SA
    Am J Pathol; 1985 Nov; 121(2):284-90. PubMed ID: 4061566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial load in animal models of acute and chronic 'reactivated' colitis.
    Hernández GA; Appleyard CB
    Digestion; 2003; 67(3):161-9. PubMed ID: 12853728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal flora in inflammatory bowel disease.
    Swidsinski A; Ladhoff A; Pernthaler A; Swidsinski S; Loening-Baucke V; Ortner M; Weber J; Hoffmann U; Schreiber S; Dietel M; Lochs H
    Gastroenterology; 2002 Jan; 122(1):44-54. PubMed ID: 11781279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules.
    Merlin D; Si-Tahar M; Sitaraman SV; Eastburn K; Williams I; Liu X; Hediger MA; Madara JL
    Gastroenterology; 2001 Jun; 120(7):1666-79. PubMed ID: 11375948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.
    Rath HC; Schultz M; Freitag R; Dieleman LA; Li F; Linde HJ; Schölmerich J; Sartor RB
    Infect Immun; 2001 Apr; 69(4):2277-85. PubMed ID: 11254584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics and inflammatory bowel diseases.
    Schultz M; Sartor RB
    Am J Gastroenterol; 2000 Jan; 95(1 Suppl):S19-21. PubMed ID: 10634224
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.